<DOC>
	<DOCNO>NCT00001890</DOCNO>
	<brief_summary>Hardening artery ( atherosclerosis ) heart disease much common men woman . However , woman grow old , especially menopause incidence atherosclerosis heart disease increase . These finding suggest estrogen may protective help prevent heart disease . Studies large group post-menopausal woman suggest hormone replacement therapy ( therapy include estrogen ) reduce risk heart disease . Estrogen cause favorable change particle carry cholesterol blood stream improve function blood vessel . Estrogen may also stimulate immune system 's ability fight infection may lead contribute atherosclerosis . Researchers believe two specific infectious agent ( Chlamydia pneumoniae human cytomegalovirus ) may cause damage line blood vessel result inflammation development atherosclerosis . The purpose study determine estrogen treatment change immune system respond chronic infection , Chlamydia pneumoniae human cytomegalovirus , postmenopausal woman .</brief_summary>
	<brief_title>Effects Hormone Therapy Immune Systems Postmenopausal Women With Chronic Infections</brief_title>
	<detailed_description>The incidence atherosclerotic cardiovascular disease woman approach rate see men approximately decade follow menopause , suggest estrogen vasculoprotective . Infectious pathogen Chlamydia pneumoniae ( C. pneumoniae ) human cytomegalovirus ( hCMV ) implicate pathogenesis atherosclerosis . Experimental study culture lymphocytes animal suggest estrogen stimulates cell-mediated immune responsiveness , observation potentially relevant eradication intracellular pathogen include C. pneumoniae hCMV . The purpose study determine whether estrogen therapy augment cell-mediated immune responsiveness estrogen-deficient postmenopausal woman serologic evidence chronic infection C. pneumoniae and/or hCMV . A comparison make seropositive seronegative woman . We propose estrogen therapy stimulate efficient cell-mediated response chronically persistent infectious intracellular pathogen , result eradication organism potential importance atherogenesis .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Must postmenopausal woman 65 year age younger . Time since last date menses least 12 month , plasma estradiol less 50 pg/ml FSH great 50 pg/ml . Women must without clinical evidence CAD determine history , cardiovascular physical examination , EKG . Must use hormone replacement therapy within past 6 month . Must use dietary supplement medication ( overthecounter prescribe ) within 1 month . Acetaminophen use allow . Must history alcoholism bingedrinking . Must diabetes mellitus know abnormal glucose intolerance test . Must history stroke , angina myocardial infarction . Must history deep venous thrombosis/pulmonary embolism . Must history cancer ( except treat squamous cell basal cell carcinoma ) . Must evidence liver disease ( liver function enzyme great twice upper limit normal ) . Must impair renal function ( creatinine great 1.6 mg/dl ) . Must diagnosis autoimmune disease ( e.g. , systemic lupus erythematosus , rheumatoid arthritis , thyroiditis , Raynaud 's Disease ) . Must history intermittent vaginal bleeding . Must serum triglyceride great 400 mg/dL .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2000</verification_date>
	<keyword>Cellular Immunity</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Estrogen</keyword>
	<keyword>Humoral Immunity</keyword>
	<keyword>Progesterone</keyword>
	<keyword>Chlamydia Pneumoniae</keyword>
	<keyword>Human Cytomegalovirus</keyword>
	<keyword>Postmenopause</keyword>
</DOC>